- Investing Ideas
- /
- Pakistani Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Pakistani Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Results
2
1 new
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
2 companies
Highnoon Laboratories
Market Cap: PK₨63.6b
Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.
HINOON
PK₨1,199.63
7D
5.4%
1Y
76.9%
Hoechst Pakistan
Market Cap: PK₨36.8b
Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
New
HPL
PK₨3,812.50
7D
26.0%
1Y
117.6%